1.
Long GV, Del Vecchio M, Weber J, Hoeller C, Grob J-J, Mohr P, Grabbe S, Dutriaux C, Chiarion-Sileni V, Mackiewicz J, Rutkowski P, Arenberger P, Quéreux G, Meniawy T, Ascierto PA, Durani P, Lobo M, Campigotto F, Gastman B, Kirkwood JM. Adjuvant therapy with nivolumab versus placebo in patients with resected stage IIB/C melanoma (CheckMate 76K). J of Skin [Internet]. 2023 Mar. 13 [cited 2024 Jul. 4];7(2):s163. Available from: https://jofskin.org/33014/index.php/skin/article/view/2021